Citaloxan and respiratory failure Patient Reports February 10, 2012



Citaloxan Side Effects Report #5811046-0
Citaloxan side effect was reported by a Consumer or non-health professional from PORTUGAL on June 25, 2008. Female patient, 30 years of age, weighting 130.1 lb, was diagnosed with hodgkin's disease What is  hodgkin's disease and was treated with Citaloxan. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea, fibrin d dimer increased, haemoconcentration, hypoxia, leukocytosis, lung infiltration, respiratory failure, vomiting. Citaloxan dosage: 3240 MG TOTAL IV. During the same period patient was treated with CISPLATIN, ETOPOSIDE, METHYLPREDNISOLONE HEMISUCCINATE, GRANISETRON, MANNITOL, SORBITOL, ALLOPURINOL, INSULIN MONOCOMPONENT. Patient died on 02/25/2008.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Citaloxan